Evidence-based, peer-reviewed studies have shown that a single dose of HA after a procedure accelerates tissue healing, enhances bone formation, and reduces probing pocket depth in various dental ...

Summit Therapeutics Inc.’s SMMT share price has dipped by 6.05%, which has investors questioning if this is right time to buy.

A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating bone disease that causes severe pain and joint collapse.

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Biocon Biologics, a subsidiary of Biocon Ltd, announced on Thursday that it has received approval from the United States Food ...

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.

Jobevne is a vascular endothelial growth factor (VEGF) impediment that sticks with VEGF and restrain the interaction with its ...

A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...

A newly presented study has uncovered troubling molecular changes in the cervix associated with a common parasitic infection, ...

Schistosoma haematobium, responsible for urogenital schistosomiasis, affects more than 110 million people worldwide.

Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP).